MX2022005892A - Produccion de celulas precursoras hematopoyeticas. - Google Patents

Produccion de celulas precursoras hematopoyeticas.

Info

Publication number
MX2022005892A
MX2022005892A MX2022005892A MX2022005892A MX2022005892A MX 2022005892 A MX2022005892 A MX 2022005892A MX 2022005892 A MX2022005892 A MX 2022005892A MX 2022005892 A MX2022005892 A MX 2022005892A MX 2022005892 A MX2022005892 A MX 2022005892A
Authority
MX
Mexico
Prior art keywords
hematopoietic precursor
cell production
precursor cell
precursor cells
hematopoietic
Prior art date
Application number
MX2022005892A
Other languages
English (en)
Inventor
Stuart Chambers
Jingli Zhang
Qingwen Cheng
Guanyi Huang
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2022005892A publication Critical patent/MX2022005892A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Abstract

Esta invención proporciona métodos mejorados para la generación de células precursoras hematopoyéticas a partir de una célula madre pluripotente y células precursoras hematopoyéticas generadas de las mismas. Las células precursoras hematopoyéticas expresan CXCR4 o runx1c y pueden dirigirse y/o injertarse en la médula ósea.
MX2022005892A 2019-11-14 2020-11-13 Produccion de celulas precursoras hematopoyeticas. MX2022005892A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962935353P 2019-11-14 2019-11-14
PCT/US2020/060582 WO2021097346A1 (en) 2019-11-14 2020-11-13 Hematopoietic precursor cell production

Publications (1)

Publication Number Publication Date
MX2022005892A true MX2022005892A (es) 2022-06-14

Family

ID=73790249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005892A MX2022005892A (es) 2019-11-14 2020-11-13 Produccion de celulas precursoras hematopoyeticas.

Country Status (9)

Country Link
US (1) US20220411755A1 (es)
EP (1) EP4058564A1 (es)
JP (1) JP2023501520A (es)
AR (1) AR120475A1 (es)
AU (1) AU2020381537A1 (es)
CA (1) CA3161465A1 (es)
MX (1) MX2022005892A (es)
TW (1) TW202132563A (es)
WO (1) WO2021097346A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4271798A1 (en) 2020-12-30 2023-11-08 CRISPR Therapeutics AG Compositions and methods for differentiating stem cells into nk cells
CN116445408B (zh) * 2023-05-22 2024-02-02 呈诺再生医学科技(北京)有限公司 LSD1抑制剂在促进iPSC向HSC分化和HSC干性维持中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197915B (en) 1986-11-19 1990-11-14 Rolls Royce Plc Improvements in or relating to fluid bearings
JP5943533B2 (ja) 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団
CA3003152A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2017192708A1 (en) * 2016-05-03 2017-11-09 The Children's Medical Center Corporation Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells

Also Published As

Publication number Publication date
CA3161465A1 (en) 2021-05-20
AR120475A1 (es) 2022-02-16
AU2020381537A1 (en) 2022-06-09
WO2021097346A1 (en) 2021-05-20
US20220411755A1 (en) 2022-12-29
JP2023501520A (ja) 2023-01-18
EP4058564A1 (en) 2022-09-21
TW202132563A (zh) 2021-09-01

Similar Documents

Publication Publication Date Title
MX2018005274A (es) Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
MX2019011040A (es) Composiciones y metodos para potenciar la expresion genica.
SG10201810723VA (en) Improved t cell compositions
IL290605A (en) Methods for the production of hematopoietic progenitor cells from pluripotent stem cells
MX2022005892A (es) Produccion de celulas precursoras hematopoyeticas.
SG10201906070XA (en) Compositions and methods for high efficiency in vivo genome editing
EP3914271A4 (en) COMPOSITIONS AND METHODS OF GENERATION OF HEMATOPOETIC STEM CELLS (HSCS)
WO2012109208A3 (en) Hematopoietic precursor cell production by programming
GB2526228A (en) Combined organ and hematopoietic cells for transplantation tolerance of grafts
MX2017010377A (es) Andamios e implantes de tejidos suaves biológicamente funcionales.
EP2190976A4 (en) METHOD FOR PRODUCING PLURIPOTENTAL STEM CELL LENGTH CELLS
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
MX2019007890A (es) Compuestos de 1h-pirrol-2,5-diona y metodos de uso de los mismos para inducir la auto-renovacion de celulas madre/progenitoras de soporte.
AU2016250905A8 (en) Generation of muscle-lineage cells from stem cells
MX2022006994A (es) Metodos para generar celulas madre hematopoyeticas.
MX2021005021A (es) Proceso para producir celulas t geneticamente modificadas.
MX2021000459A (es) Metodo para producir celulas t gamma y delta.
IL282637A (en) Methods for allogeneic transplantation of hematopoietic stem cells
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
WO2020074925A3 (en) Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
MX2019010249A (es) Particulas pm21 para mejorar el anidamiento de la medula osea de celulas nk.
PH12018502061A1 (en) Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
AU2019377278C1 (en) Anchorage-independent cells and use thereof
WO2021092581A9 (en) Generation of engineered regulatory t cells
NZ747910A (en) Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells